SCHEMBL7807908

SCHEMBL7807908

N#Cc1ccc(C(=O)Nc2ccc(Cl)c(NC(=O)c3ccc(OCCc4ncc[nH]4)cc3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.47
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MLLT1 Q03111 1/20 0.40
MAPT P10636 4/20 0.40
TP53 P04637 2/20 0.40
NAMPT P43490 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
POLB P06746 1/20 0.39
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
KLKB1 P03952 1/20 0.39
PRSS1 P07477 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6682415 0.79 MEN1 (0.60) ESR1KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL6476742 0.79 TBXAS1 (0.59) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL6678076 0.76 KMT2A (0.52) ESR1KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL8687549 0.76 TBXAS1 (0.44) ALDH1A1MAPT
SCHEMBL7806491 0.74 TBXAS1 (0.57) LMNAMEN1KMT2A
SCHEMBL5897778 0.73 TSHR (0.65) KDM4EALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL5897360 0.72 PABPC1 (0.56) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL6677237 0.71 MAPK14 (0.65) KDM4EALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL6485161 0.71 MAPK14 (0.67) ESR1ALDH1A1MEN1KMT2ANPC1
SCHEMBL7296470 0.70 TBXAS1 (0.43) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077931-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES AstraZeneca AB (SE) 2001-02-28 EP claimed
WO-1999059959-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES ASTRAZENECA AB (SE) 1999-11-25 WO claimed
EP-1077931-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES AstraZeneca AB (SE) 2001-02-28 EP disclosed
WO-1999059959-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES ASTRAZENECA AB (SE) 1999-11-25 WO disclosed